1 |
Galal M, Bahaa M, Ibrahim WA, Elshafie AI, Sedrak CR. Pretransplantation α-fetoprotein level as a predictor of hepatocellular carcinoma recurrence after adult living donor liver transplantation within milan criteria in egyptian patients. Egypt J Intern Med 2019;31:203-7. [DOI: 10.4103/ejim.ejim_106_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
2 |
Lozanovski VJ, Ramouz A, Aminizadeh E, Al-Saegh SA, Khajeh E, Probst H, Picardi S, Rupp C, Chang DH, Probst P, Mehrabi A. Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis. BJS Open 2022;6:zrab130. [PMID: 35211739 DOI: 10.1093/bjsopen/zrab130] [Reference Citation Analysis]
|
3 |
Eilard MS, Naredi P, Helmersson M, Hemmingsson O, Isaksson B, Lindell G, Sandström P, Strömberg C, Rizell M. Survival and prognostic factors after transplantation, resection and ablation in a national cohort of early hepatocellular carcinoma. HPB 2021;23:394-403. [DOI: 10.1016/j.hpb.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Hu X, Chen R, Wei Q, Xu X. The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We? Int J Biol Sci 2022;18:536-51. [PMID: 35002508 DOI: 10.7150/ijbs.64537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|